Notice Regarding Substance Abuse and Mental Health Services Administration's National Registry of Evidence-Based Programs and Practices (NREPP): Open Submission Period for Fiscal Year 2010, 29706-29708 [E9-14621]
Download as PDF
29706
Federal Register / Vol. 74, No. 119 / Tuesday, June 23, 2009 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Annual
Estimates of Influenza Vaccine
Effectiveness for Preventing
Laboratory Confirmed Influenza in the
United States, Funding Opportunity
Announcement (FOA) IP08–
00101SUPP10, Initial Review
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 1 p.m.–3 p.m., August 12,
2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of ‘‘Annual Estimates of Influenza
Vaccine Effectiveness for Preventing
Laboratory Confirmed Influenza in the
United States, FOA IP08–00101SUPP10.’’
For More Information Contact: Gregory
Anderson, M.P.H., M.S., CDC, 1600 Clifton
Road, NE., Mailstop E60, Atlanta, GA 30333,
Telephone: (404) 498–2275.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: June 12, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–14658 Filed 6–22–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
VerDate Nov<24>2008
16:15 Jun 22, 2009
Jkt 217001
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, NCI–ARRA
P30 Biomedical Research Core Centers
Review.
Date: July 20–21, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Bethesda North Hotel &
Conference Center, Bethesda, MD 20852.
Contact Person: Bratin K. Saha, PhD,
Scientific Review Officer, Program
Coordination and Referral Branch, Division
of Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Room 8041, Bethesda, MD 20892. (301) 402–
0371. sahab@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control; 93.701, ARRA Related
Biomedical Research and Research Support
Awards, National Institutes of Health, HHS).
Dated: June 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–14699 Filed 6–22–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel. RC2 Medical Sequencing.
Date: July 15–16, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott and
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Rudy O. Pozzatti, PhD,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, 5635 Fishers Lane, Suite 4076, MSC
9306, Rockville, MD 20852. (301) 402–0838.
pozzattr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: June 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–14698 Filed 6–22–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Notice Regarding Substance Abuse
and Mental Health Services
Administration’s National Registry of
Evidence-Based Programs and
Practices (NREPP): Open Submission
Period for Fiscal Year 2010
AGENCY: Substance Abuse and Mental
Health Services Administration.
ACTION: Notice regarding Substance
Abuse and Mental Health Services
Administration’s National Registry of
Evidence-based Programs and Practices
(NREPP): Open submission period for
Fiscal Year 2010.
SUMMARY: The Substance Abuse and
Mental Health Services Administration
(SAMHSA) is committed to preventing
the onset and reducing the progression
of mental illness, substance abuse, and
substance-related problems among all
individuals. As part of this effort,
SAMHSA has expanded and refined the
agency’s National Registry of Evidencebased Programs and Practices (NREPP).
Two previous notices announcing these
changes have been published in the
Federal Register (70 FR 50381, Aug. 26,
2005; 71 FR 13133, Mar. 14, 2006).
Since 2006, SAMHSA has held two
open submission periods during which
interventions could be submitted for
potential review and inclusion on the
NREPP Web site (71 FR 37590, June 30,
2006; 72 FR 30814, June 4, 2007). This
notice announces the open submission
period for fiscal year 2010, explains
E:\FR\FM\23JNN1.SGM
23JNN1
Federal Register / Vol. 74, No. 119 / Tuesday, June 23, 2009 / Notices
how submissions will be screened and
selected, and provides guidance on the
submission process for individuals and
organizations seeking to have an
intervention reviewed and listed on the
NREPP Web site. Potential applicants
should be aware that this notice
includes new information relating to the
eligibility of interventions and the
review process that supersedes guidance
provided in earlier Federal Register
notices.
FOR FURTHER INFORMATION CONTACT:
Kevin D. Hennessy, Ph.D., Science to
Service Coordinator/SAMHSA, 1 Choke
Cherry Road, Room 8–1017, Rockville,
MD 20857, (240) 276–2234.
NREPP as an exclusive or exhaustive list
of interventions is not appropriate.
Policymakers and funders in particular
are discouraged from limiting
contracted providers and/or potential
grantees to selecting only among NREPP
interventions.
This notice announces the next open
submission period during which
SAMHSA will consider and accept new
applications for review, describes the
minimum requirements and other
considerations that will be used in
screening and selecting interventions,
and provides guidance on the
submission process.
Dated: June 16, 2009.
Eric B. Broderick,
Acting Administrator, SAMHSA Assistant
Surgeon General.
SAMHSA has established a 4-month
period for receipt of NREPP submissions
for fiscal year 2010 that will begin
October 1, 2009, and end February 1,
2010. Interventions submitted after
February 1, 2010, will not be considered
during this submission cycle. Program
developers, researchers, and others
interested in submitting an intervention
should read this notice for information
about current minimum requirements
and examine the information provided
on the NREPP Web site about the review
process and review criteria (https://
nrepp.sarnhsa.gov/review.asp). The
selection of interventions will take place
after the closing of the open submission
period, and applicants will be informed
of their acceptance status at that time.
The number of reviews conducted will
depend on the availability of funds,
with the final selection of interventions
and the timing of reviews to be
determined at the discretion of
SAMHSA.
In submitting an intervention,
applicants understand that the results of
NREPP reviews are considered public
information and will be posted on the
NREPP Web site. Once a review is
completed, the applicant will be
provided with a summary document
(‘‘intervention summary’’) that presents
ratings and descriptive information
about the intervention. Applicants are
Substance Abuse and Mental Health
Services Administration’s National
Registry of Evidence-based Programs
and Practices (NREPP): Open
Submission Period for Fiscal Year 2010
Background
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA) National Registry of
Evidence-based Programs and Practices
(NREPP) is a voluntary rating system
designed to provide the public with
reliable information about interventions
that promote mental health or prevent
or treat mental illness, substance use
disorders, or co-occurring disorders.
Programs and practices that are
accepted for inclusion in the registry
undergo two independent review
processes in which their (1) quality of
research and (2) readiness for
dissemination are evaluated and rated.
The results of these reviews are
published on the NREPP Web site
(https://nrepp.samhsa.gov).
It should be noted that inclusion in
NREPP does not constitute endorsement
of an intervention by SAMHSA.
Moreover, since NREPP has not
reviewed all interventions, the use of
Dates of Open Submission Period
29707
encouraged to view examples of NREPP
intervention summaries on the NREPP
Web site to become familiar with the
end product of the review process.
Minimum Requirements
To be considered for review,
interventions must meet four minimum
requirements:
1. The intervention has produced one
or more positive behavioral outcomes
(p≤.O5) in mental health or substance
use among individuals, communities, or
populations.
2. Evidence of these outcomes has
been demonstrated in at least one study
using an experimental or quasiexperimental design. Experimental
designs require random assignment, a
control or comparison group, and preand postintervention assessments.
Quasi-experimental designs do not
require random assignment but do
require a comparison or control group
and pre- and postintervention
assessments; this category includes
longitudinal/multiple time series
designs with at least three
preintervention or baseline
measurements and at least three
postintervention or follow-up
measurements.
3. The results of these studies have
been published in a peer-reviewed
journal or other publication or
documented in a comprehensive
evaluation report. Comprehensive
evaluation reports must include a
review of the literature, theoretical
framework, purpose, methodology,
findings/results, discussion, and
conclusions.
4. Implementation materials, training
and support resources, and quality
assurance procedures have been
developed and are ready for use by the
public.
Applicants are required to provide
documentation at the time of
submission that demonstrates that the
intervention meets these minimum
requirements. Table 1 lists examples of
appropriate supporting documentation.
TABLE 1—DOCUMENTATION FOR DEMONSTRATING COMPLIANCE WITH MINIMUM REQUIREMENTS
Minimum requirement
Quality of Research .................................
VerDate Nov<24>2008
16:15 Jun 22, 2009
Jkt 217001
Documentation
1. Intervention has produced one or
more positive behavioral outcomes
(p. ≤ .05) in mental health or substance use among individuals, communities, or populations.
2. Evidence of these outcomes has
been demonstrated in at least one
study using an experimental or
quasiexperimental design.
A list of significant behavioral outcomes that includes supporting citations for each outcome; and
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
A full-text copy of each article/report cited in the list of outcomes. Other research articles, published or unpublished
evaluation reports, grant final reports, and replication
studies may be submitted as additional supporting documentation.
E:\FR\FM\23JNN1.SGM
23JNN1
29708
Federal Register / Vol. 74, No. 119 / Tuesday, June 23, 2009 / Notices
TABLE 1—DOCUMENTATION FOR DEMONSTRATING COMPLIANCE WITH MINIMUM REQUIREMENTS—Continued
Minimum requirement
Readiness for Dissemination ...................
Documentation
3. Results of these studies have been
published in a peer-reviewed journal
or other publication or documented in
a comprehensive evaluation report.
4. Implementation materials, training
and support resources, and quality
assurance procedures have been developed and are ready for use by the
public.
Note: Abstracts or URLs to partial articles are regarded as
incomplete and will not be considered.
The following types of interventions
are not eligible for review and should
not be submitted to NREPP:
1. Stand-alone pharmacologic
treatments—The evidence base for
pharmacologic treatments is reviewed
and approved through the U.S. Food
and Drug Administration (FDA). FDAapproved pharmacotherapy
interventions (on label use) are
considered for NREPP review only
when combined with one or more
behavioral or psychosocial treatments.
2. Stand-alone smoking prevention
and/or cessation interventions—
Interventions to prevent or reduce
tobacco use are eligible for NREPP
review only when conducted as part of
a program that also addresses the
prevention or treatment of alcohol or
other drugs of abuse.
Selection of Interventions for Review
All submissions meeting the
minimum requirements will be
considered eligible for review. The
priority point system described in past
Federal Register notices will no longer
be used in the prioritization of
submissions. In selecting interventions
for review, SAMHSA may choose to
give special consideration to
interventions that meet one or more of
the following conditions:
• The original investigator(s) or an
independent party has used the same
protocol with an identical or similar
target population, and/or has used a
slightly modified protocol based on a
slightly modified population, where
results are consistent with positive
findings from the original evaluation.
• Implementation materials (e.g.,
program manuals, training guides,
measurement instruments,
implementation fidelity guides) are
available to the public at no cost.
• The intervention targets
underserved populations (e.g., minority
populations, elderly, young adults, and
individuals who are incarcerated). The
intervention contributes to a content
VerDate Nov<24>2008
16:15 Jun 22, 2009
Jkt 217001
Brief narrative description and list of available materials, resources, and systems to support implementation (e.g.,
treatment manuals, information for administrators, tested
training curricula, mechanisms for ongoing supervision
and consultation, protocols for gathering process and
outcome data, ongoing monitoring of intervention fidelity,
processes for gathering feedback).
area where there are currently limited
evidence-based interventions.
by NREPP staff once the review has
been completed.
Interventions that are not selected for
review may be resubmitted by the
applicant in a future open submission
period.
Contact Information
Individuals who have questions about
the information contained in this notice
may write to NREPP staff at
nrepp@samhsa.hhs.gov or call 1–866–
436–7377.
Instructions for Submitting an
Intervention
To submit an intervention,
individuals should send a written
statement to NREPP expressing their
interest along with documentation that
demonstrates that the intervention
meets the minimum requirements as
described above. All submissions must
be made either by a principal
investigator (PI) who has conducted
research on the intervention, a project
director (PD) who has worked with an
evaluator of the intervention, or a
formally authorized delegate of the PI or
PD. For information on where to submit
materials, please call 1–866–436–7377.
Electronic submissions are preferred,
but materials may be sent to NREPP in
hard copy via postal mail or fax. To be
eligible for consideration, submissions
must be received no later than 11:59 pm
EST on February 1, 2010; those received
before October 1, 2009, will be
disregarded.
If an intervention is accepted, the PI
will be contacted and asked to submit
additional documentation to be used in
the review. This additional
documentation includes full-text copies
of all articles and reports that provide
evidence of significant outcomes
(p≤.O5) as well as 8 copies of selected
dissemination materials in the format
they are provided to the public (e.g.,
hard copies or electronic versions of
manuals, training presentations, tools,
quality assurance protocols; URLs for
interactive Web-based resources).
The PI is expected to serve as the
main point of contact throughout the
remainder of the review process,
including approval of the final
intervention summary that is developed
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
[FR Doc. E9–14621 Filed 6–22–09; 8:45 am]
BILLING CODE 4160–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Recruitment of Sites for Assignment of
Corps Personnel Obligated Under the
National Health Service Corps
Scholarship Program
AGENCY: Health Resources and Services
Administration, HHS.
ACTION: General notice.
SUMMARY: The Health Resources and
Services Administration (HRSA)
announces that the listing of entities,
and their Health Professional Shortage
Area (HPSA) scores, that will receive
priority for the assignment of National
Health Service Corps (NHSC)
scholarship recipients (Corps Personnel,
Corps members) during the period July
1, 2009, through June 30, 2010, is posted
on the NHSC Web site at https://
nhscjobs.hrsa.gov/. This list specifies
which entities are eligible to receive
assignment of Corps members who are
participating in the NHSC Scholarship
Program. A separate Federal Register
Notice pertaining to sites eligible to
receive NHSC Loan Repayment Program
participants and non-obligated
individuals was published on May 28,
2009 (74 FR 25568). Please note that not
all vacancies associated with sites on
the list described below will be for
Corps members, but could be for NHSC
Scholarship Program participants
E:\FR\FM\23JNN1.SGM
23JNN1
Agencies
[Federal Register Volume 74, Number 119 (Tuesday, June 23, 2009)]
[Notices]
[Pages 29706-29708]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-14621]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Notice Regarding Substance Abuse and Mental Health Services
Administration's National Registry of Evidence-Based Programs and
Practices (NREPP): Open Submission Period for Fiscal Year 2010
AGENCY: Substance Abuse and Mental Health Services Administration.
ACTION: Notice regarding Substance Abuse and Mental Health Services
Administration's National Registry of Evidence-based Programs and
Practices (NREPP): Open submission period for Fiscal Year 2010.
-----------------------------------------------------------------------
SUMMARY: The Substance Abuse and Mental Health Services Administration
(SAMHSA) is committed to preventing the onset and reducing the
progression of mental illness, substance abuse, and substance-related
problems among all individuals. As part of this effort, SAMHSA has
expanded and refined the agency's National Registry of Evidence-based
Programs and Practices (NREPP). Two previous notices announcing these
changes have been published in the Federal Register (70 FR 50381, Aug.
26, 2005; 71 FR 13133, Mar. 14, 2006). Since 2006, SAMHSA has held two
open submission periods during which interventions could be submitted
for potential review and inclusion on the NREPP Web site (71 FR 37590,
June 30, 2006; 72 FR 30814, June 4, 2007). This notice announces the
open submission period for fiscal year 2010, explains
[[Page 29707]]
how submissions will be screened and selected, and provides guidance on
the submission process for individuals and organizations seeking to
have an intervention reviewed and listed on the NREPP Web site.
Potential applicants should be aware that this notice includes new
information relating to the eligibility of interventions and the review
process that supersedes guidance provided in earlier Federal Register
notices.
FOR FURTHER INFORMATION CONTACT: Kevin D. Hennessy, Ph.D., Science to
Service Coordinator/SAMHSA, 1 Choke Cherry Road, Room 8-1017,
Rockville, MD 20857, (240) 276-2234.
Dated: June 16, 2009.
Eric B. Broderick,
Acting Administrator, SAMHSA Assistant Surgeon General.
Substance Abuse and Mental Health Services Administration's National
Registry of Evidence-based Programs and Practices (NREPP): Open
Submission Period for Fiscal Year 2010
Background
The Substance Abuse and Mental Health Services Administration's
(SAMHSA) National Registry of Evidence-based Programs and Practices
(NREPP) is a voluntary rating system designed to provide the public
with reliable information about interventions that promote mental
health or prevent or treat mental illness, substance use disorders, or
co-occurring disorders. Programs and practices that are accepted for
inclusion in the registry undergo two independent review processes in
which their (1) quality of research and (2) readiness for dissemination
are evaluated and rated. The results of these reviews are published on
the NREPP Web site (https://nrepp.samhsa.gov).
It should be noted that inclusion in NREPP does not constitute
endorsement of an intervention by SAMHSA. Moreover, since NREPP has not
reviewed all interventions, the use of NREPP as an exclusive or
exhaustive list of interventions is not appropriate. Policymakers and
funders in particular are discouraged from limiting contracted
providers and/or potential grantees to selecting only among NREPP
interventions.
This notice announces the next open submission period during which
SAMHSA will consider and accept new applications for review, describes
the minimum requirements and other considerations that will be used in
screening and selecting interventions, and provides guidance on the
submission process.
Dates of Open Submission Period
SAMHSA has established a 4-month period for receipt of NREPP
submissions for fiscal year 2010 that will begin October 1, 2009, and
end February 1, 2010. Interventions submitted after February 1, 2010,
will not be considered during this submission cycle. Program
developers, researchers, and others interested in submitting an
intervention should read this notice for information about current
minimum requirements and examine the information provided on the NREPP
Web site about the review process and review criteria (https://nrepp.sarnhsa.gov/review.asp). The selection of interventions will take
place after the closing of the open submission period, and applicants
will be informed of their acceptance status at that time. The number of
reviews conducted will depend on the availability of funds, with the
final selection of interventions and the timing of reviews to be
determined at the discretion of SAMHSA.
In submitting an intervention, applicants understand that the
results of NREPP reviews are considered public information and will be
posted on the NREPP Web site. Once a review is completed, the applicant
will be provided with a summary document (``intervention summary'')
that presents ratings and descriptive information about the
intervention. Applicants are encouraged to view examples of NREPP
intervention summaries on the NREPP Web site to become familiar with
the end product of the review process.
Minimum Requirements
To be considered for review, interventions must meet four minimum
requirements:
1. The intervention has produced one or more positive behavioral
outcomes (p<=.O5) in mental health or substance use among individuals,
communities, or populations.
2. Evidence of these outcomes has been demonstrated in at least one
study using an experimental or quasi-experimental design. Experimental
designs require random assignment, a control or comparison group, and
pre- and postintervention assessments. Quasi-experimental designs do
not require random assignment but do require a comparison or control
group and pre- and postintervention assessments; this category includes
longitudinal/multiple time series designs with at least three
preintervention or baseline measurements and at least three
postintervention or follow-up measurements.
3. The results of these studies have been published in a peer-
reviewed journal or other publication or documented in a comprehensive
evaluation report. Comprehensive evaluation reports must include a
review of the literature, theoretical framework, purpose, methodology,
findings/results, discussion, and conclusions.
4. Implementation materials, training and support resources, and
quality assurance procedures have been developed and are ready for use
by the public.
Applicants are required to provide documentation at the time of
submission that demonstrates that the intervention meets these minimum
requirements. Table 1 lists examples of appropriate supporting
documentation.
Table 1--Documentation for Demonstrating Compliance With Minimum Requirements
----------------------------------------------------------------------------------------------------------------
Minimum requirement Documentation
----------------------------------------------------------------------------------------------------------------
Quality of Research................... 1. Intervention has produced A list of significant behavioral
one or more positive outcomes that includes supporting
behavioral outcomes (p. <= citations for each outcome; and
.05) in mental health or
substance use among
individuals, communities, or
populations.
2. Evidence of these outcomes A full-text copy of each article/report
has been demonstrated in at cited in the list of outcomes. Other
least one study using an research articles, published or
experimental or unpublished evaluation reports, grant
quasiexperimental design. final reports, and replication studies
may be submitted as additional
supporting documentation.
[[Page 29708]]
3. Results of these studies Note: Abstracts or URLs to partial
have been published in a peer- articles are regarded as incomplete and
reviewed journal or other will not be considered.
publication or documented in
a comprehensive evaluation
report.
Readiness for Dissemination........... 4. Implementation materials, Brief narrative description and list of
training and support available materials, resources, and
resources, and quality systems to support implementation
assurance procedures have (e.g., treatment manuals, information
been developed and are ready for administrators, tested training
for use by the public. curricula, mechanisms for ongoing
supervision and consultation, protocols
for gathering process and outcome data,
ongoing monitoring of intervention
fidelity, processes for gathering
feedback).
----------------------------------------------------------------------------------------------------------------
The following types of interventions are not eligible for review
and should not be submitted to NREPP:
1. Stand-alone pharmacologic treatments--The evidence base for
pharmacologic treatments is reviewed and approved through the U.S. Food
and Drug Administration (FDA). FDA-approved pharmacotherapy
interventions (on label use) are considered for NREPP review only when
combined with one or more behavioral or psychosocial treatments.
2. Stand-alone smoking prevention and/or cessation interventions--
Interventions to prevent or reduce tobacco use are eligible for NREPP
review only when conducted as part of a program that also addresses the
prevention or treatment of alcohol or other drugs of abuse.
Selection of Interventions for Review
All submissions meeting the minimum requirements will be considered
eligible for review. The priority point system described in past
Federal Register notices will no longer be used in the prioritization
of submissions. In selecting interventions for review, SAMHSA may
choose to give special consideration to interventions that meet one or
more of the following conditions:
The original investigator(s) or an independent party has
used the same protocol with an identical or similar target population,
and/or has used a slightly modified protocol based on a slightly
modified population, where results are consistent with positive
findings from the original evaluation.
Implementation materials (e.g., program manuals, training
guides, measurement instruments, implementation fidelity guides) are
available to the public at no cost.
The intervention targets underserved populations (e.g.,
minority populations, elderly, young adults, and individuals who are
incarcerated). The intervention contributes to a content area where
there are currently limited evidence-based interventions.
Interventions that are not selected for review may be resubmitted by
the applicant in a future open submission period.
Instructions for Submitting an Intervention
To submit an intervention, individuals should send a written
statement to NREPP expressing their interest along with documentation
that demonstrates that the intervention meets the minimum requirements
as described above. All submissions must be made either by a principal
investigator (PI) who has conducted research on the intervention, a
project director (PD) who has worked with an evaluator of the
intervention, or a formally authorized delegate of the PI or PD. For
information on where to submit materials, please call 1-866-436-7377.
Electronic submissions are preferred, but materials may be sent to
NREPP in hard copy via postal mail or fax. To be eligible for
consideration, submissions must be received no later than 11:59 pm EST
on February 1, 2010; those received before October 1, 2009, will be
disregarded.
If an intervention is accepted, the PI will be contacted and asked
to submit additional documentation to be used in the review. This
additional documentation includes full-text copies of all articles and
reports that provide evidence of significant outcomes (p<=.O5) as well
as 8 copies of selected dissemination materials in the format they are
provided to the public (e.g., hard copies or electronic versions of
manuals, training presentations, tools, quality assurance protocols;
URLs for interactive Web-based resources).
The PI is expected to serve as the main point of contact throughout
the remainder of the review process, including approval of the final
intervention summary that is developed by NREPP staff once the review
has been completed.
Contact Information
Individuals who have questions about the information contained in
this notice may write to NREPP staff at nrepp@samhsa.hhs.gov or call 1-
866-436-7377.
[FR Doc. E9-14621 Filed 6-22-09; 8:45 am]
BILLING CODE 4160-01-M